36 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
months, respectively). These results will be presented as a late-breaking abstract at the 2024 American Society of Clinical Oncology (ASCO) Annual … interim long-term data from the Phase 3 EMERGENT program at the Annual Congress of the Schizophrenia International Research Society (SIRS).
◦In the new
8-K
EX-99.1
ZLAB
Zai Lab Limited
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
Society of Medical Oncology Congress (ESMO) 2023. The results demonstrate a manageable safety profile and early signs of durability of adagrasib
8-K
EX-99.1
o6u4xmfl9
6 Jun 23
Other Events
8:08am
8-K
EX-99.1
ac0 am8frg
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
1va39d0ptodr90089qi
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
8-K
EX-99.1
m3z1f89 24xm99c5
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
ard59c
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
egtqxm3sht8ikx 9awp1
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.1
pmstrkqoc1t2b0
6 Jan 22
Zai Lab Announces NDA Acceptance of
7:44am
8-K
EX-99.1
6azut4x is8
9 Aug 21
Zai Lab Announces Second Quarter 2021
4:06pm
8-K
EX-99.1
xowqmbxq
31 Mar 21
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal
7:32am
8-K
EX-99.1
k0o1 bh86
1 Mar 21
Zai Lab Announces Financial Results
7:01am
10-K
znj3i 22qvyjtn6
1 Mar 21
Annual report
12:00am